Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint - Concepedia

Concepedia

Publication | Open Access

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint

DOI Full Paper Access

50

Citations

28

References

2019

Year

Adam M. Staffaroni, Lynn Bajorek, Kaitlin B. Casaletto, Yann Cobigo, Sheng‐Yang M. Goh, Amy Wolf, Hilary W. Heuer, Fanny M. Elahi, Peter A. Ljubenkov, Reilly Dever,

Alzheimer s & Dementia

Abstract

The NIH-EXAMINER is sensitive to cognitive changes in presymptomatic familial FTLD and is a promising surrogate endpoint.

References

	Year	Citations

Page 1